General Catalyst Group Management, LLC has filed its 13F form on August 14, 2024 for Q2 2024 where it was disclosed a total value porftolio of $1.1 Billion distributed in 11 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Samsara Inc. with a value of $886M, Warby Parker Inc. with a value of $90.8M, Gitlab Inc. with a value of $45.8M, Oscar Health, Inc. with a value of $33.3M, and Evolv Technologies Holdings, Inc. with a value of $27.5M.

Examining the 13F form we can see an decrease of $122M in the current position value, from $1.23B to 1.1B.

Below you can find more details about General Catalyst Group Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $1.1 Billion
Technology: $953 Million
Healthcare: $124 Million
Industrials: $27.5 Million
Consumer Cyclical: $355,000

Stock Holdings Table Companies Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 11
  • Current Value $1.1 Billion
  • Prior Value $1.23 Billion
  • Filing
  • Period Q2 2024
  • Filing Date August 14, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 1 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track General Catalyst Group Management, LLC Portfolio

Follow General Catalyst Group Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of General Catalyst Group Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on General Catalyst Group Management, LLC with notifications on news.